Thymic hyperplasia following chemotherapy of a testicular germ cell tumor. Immunohistological evidence for a simple rebound phenomenon

Cancer. 1989 Feb 1;63(3):446-9. doi: 10.1002/1097-0142(19890201)63:3<446::aid-cncr2820630309>3.0.co;2-n.

Abstract

Diffuse thymic hyperplasia after chemotherapy of a mixed testicular germ cell tumor is reported in a 16-year-old patient. The immunohistologic investigation of the enlarged thymus revealed a normal distribution and antigen expression of lymphocytes and epithelial cells. There was no evidence of selective proliferation of lymphocytic or nonlymphocytic subpopulations within the thymus. Thus, our data corroborate the identification of thymic enlargement after chemotherapy as a simple rebound phenomenon.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Biomarkers, Tumor / analysis
  • Combined Modality Therapy
  • Follow-Up Studies
  • Humans
  • Hyperplasia
  • Immunohistochemistry
  • Male
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Neoplasms, Germ Cell and Embryonal / surgery
  • Orchiectomy
  • Remission Induction
  • Testicular Neoplasms / drug therapy*
  • Testicular Neoplasms / surgery
  • Thymectomy
  • Thymus Gland / analysis
  • Thymus Gland / drug effects
  • Thymus Gland / pathology*

Substances

  • Biomarkers, Tumor